# Evolus (EOLS) — Overview

EOLS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/eols

## Price

Last close $7.66 on Oct 15, 2026. 52-week range $3.94 – $9.30.

## Company profile

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $316.5M |
| Revenue (quarter) | $84.1M |
| Revenue growth (year over year) | 21.18% |
| Gross profit (trailing twelve months) | $211.2M |
| Gross margin | 66.74% |
| Net income (trailing twelve months) | −$34.3M |
| Net income (quarter) | −$8.1M |
| Net income growth (year over year) | 53.03% |
| Net margin | -10.85% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | −$0.53 |
| Book value per share | −$0.47 |
| P/E (trailing twelve months) | — |
| Price to book | — |
| Debt to assets | 112.46% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Evolus (EOLS) profitable?

No. Evolus reported a net loss of $34.3M over the trailing twelve months.

### How much revenue does Evolus (EOLS) make?

Evolus generated $316.5M in revenue over the trailing twelve months, up 21.18% year over year.

### How do I buy stock in Evolus (EOLS)?

EOLS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).